James M Daly

Director · 7 filings · Latest: Oct 1, 2026

ACADIA PHARMACEUTICALS INC

CYTOKINETICS INC

HALOZYME THERAPEUTICS, INC.

MADRIGAL PHARMACEUTICALS, INC.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
ACAD	James M Daly	Director	May 29, 2026	Option Exercise	—	8,107	—	12,148	Jun 1 10:00 PM
ACAD	James M Daly	—	Nov 10, 2025	Proposed Sale	$22.37	30,000	$671.0K	—	Nov 10 10:59 PM
MDGL	JAMES M DALY	—	Feb 27, 2025	Proposed Sale	$347.45	15,470	$5.4M	—	Feb 27 9:54 PM